Sarah is an accomplished regulatory strategist who joined Quantum in June 2023 as a Principal Regulatory Strategist. She brings over 25 years of global regulatory affairs expertise from both the Sponsor (pharma, biotech, and medical device) and consulting sides, with experience in a wide range of therapeutic areas including cardio-renal, rare disease and oncology. Sarah has supported global product development, regulatory approval, and successful commercialization of pipeline assets by fostering collaborative and cross-functional partnerships and exercising regulatory rigor, pragmatism, and innovative strategic thinking. In addition, Sarah has a background in veterinary pharmaceuticals and related filings.